New England Capital Financial Advisors LLC Biogen Inc. Transaction History
New England Capital Financial Advisors LLC
- $193 Billion
- Q3 2024
A detailed history of New England Capital Financial Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 63 shares of BIIB stock, worth $9,450. This represents 0.01% of its overall portfolio holdings.
Number of Shares
63
Previous 113
44.25%
Holding current value
$9,450
Previous $26.2 Million
53.38%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,037Shares Held
126MCall Options Held
1.13MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.5 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.45 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.18 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.1 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$789 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.6B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...